Tianjin Clin-Nov Medical Technology Co., Ltd.

Tianjin Clin-Nov Medical Technology Co., Ltd.

天津凯诺医药科技发展有限公司(以下简称“凯诺医药”)是凯莱英医药集团(股票代码:002821.SZ/6821.HK)(以下简称“凯莱英”)旗下全资子公司。业务范围涵盖从新药IND到NDA的一站式全流程,形成了包括从Pre-IND咨询、注册事务、临床监查、临床研究项目管理、SMO服务、数据管理与统计编程、第三方稽查、药物警戒直至上市后研究的整体闭环解决方案。 依托母公司凯莱英的强大基础,凯诺医药与凯莱英CDMO团队形成协同,实现创新药物全生命周期“研发+生产”的一站式综合服务,提高服务客户的深度和广度,创新整合资源,加速药品上市,造福广大患者。

Visit Website

Accreditations

Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.